Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host protein assembly machinery refers to the collective cellular apparatus, including molecular chaperones, the endoplasmic reticulum (ER), and various enzymes, that facilitates the folding and assembly of proteins into functional structures. In the context of pharmacology, this term is often used to describe the host systems hijacked by viruses to produce viral progeny or by cancer cells to maintain the stability of mutated proteins. While specific components of this machinery, such as Heat Shock Protein 90 (HSP90) or Valosin-containing protein (VCP/p97), are validated therapeutic targets, the term 'Host protein assembly machinery' itself is a broad biological concept rather than a single discrete molecular target. Targeting these pathways aims to disrupt the production of pathogenic proteins, though it carries significant risks of systemic toxicity because these processes are vital for the survival of healthy cells.
Inhibition of host-mediated protein folding or assembly to prevent viral maturation or oncogenic protein stability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host protein assembly machinery.